Author

F. Vailllant

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

A. Strasser· 1 shared C. Chang· 1 shared C. Riffkin· 1 shared D. Huang· 1 shared E. Lieschke· 1 shared G. Kelly· 1 shared J. E. Visvader· 1 shared M. J. Herold· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Strasser

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Loss of mutant TP53 does not impair the sustained proliferation, survival ormetastasis of diverse cancer cells

Z. Wang, F. Vailllant, C. Chang, C. Riffkin, E. Lieschke, S. Diepstraten, D. Huang, J. E. Visvader, M. J. Herold, G. Kelly, A. Strasser

This study shows that removing mutant TP53 does not affect cancer cell survival, proliferation, or metastasis, suggesting GOF effects are not universally required for malignant growth.

bioRxiv · Mar 30, 2020 · PreprintCancer Biology